Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Lung Neuroendocrine Neoplasm
- Metastatic Lung Non-Small Cell Carcinoma
- Metastatic Lung Small Cell Carcinoma
- Metastatic Malignant Neoplasm in the Brain
- Stage IV Lung Cancer AJCC v8
- Stage IVA Lung Cancer AJCC v8
- Stage IVB Lung Cancer AJCC v8
Interventions
- DRUG: Berzosertib
- OTHER: Quality-of-Life Assessment
- PROCEDURE: Therapeutic Conventional Surgery
- RADIATION: Whole-Brain Radiotherapy
Sponsor
National Cancer Institute (NCI)